azacitidine and Opportunistic Infections

azacitidine has been researched along with Opportunistic Infections in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abboud, CN; Ali, AM; Cashen, AF; DiPersio, JF; Fehniger, TA; Gao, F; Ghobadi, A; Jacoby, MA; Oh, ST; Pusic, I; Romee, R; Schroeder, MA; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Wartman, LD; Weisel, D; Welch, JS; Westervelt, P	1
Alunni Fegatelli, D; Breccia, M; Colafigli, G; Efficace, F; Foà, R; Latagliata, R; Mancini, M; Molica, M; Rizzo, L; Scalzulli, E	1
Jehn, U	1

Trials

1 trial(s) available for azacitidine and Opportunistic Infections

Article	Year
Long-term outcome of postremission chemotherapy for adults with acute myeloid leukemia using different dose-intensities. Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Germany; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Opportunistic Infections; Patient Acceptance of Health Care; Preleukemia; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine	1994

Article

Year

Long-term outcome of postremission chemotherapy for adults with acute myeloid leukemia using different dose-intensities.

Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Germany; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Opportunistic Infections; Patient Acceptance of Health Care; Preleukemia; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine

1994

Other Studies

2 other study(ies) available for azacitidine and Opportunistic Infections

Article	Year
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen. Cancer medicine, 2017, Volume: 6, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Missouri; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Virus Diseases	2017
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice. Annals of hematology, 2019, Volume: 98, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Opportunistic Infections; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome	2019

Article

Year

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.

Cancer medicine, 2017, Volume: 6, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Missouri; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Virus Diseases

2017

Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice.

Annals of hematology, 2019, Volume: 98, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Opportunistic Infections; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome

2019